Track the Orchestra BioMed Holdings, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €311.6m. The latest transaction was filed on 8 September 2026 (Acquisition). Among the most active insiders: Hochman David P. All data is openly available.
139
Insider Decl.
n/a
Thresholds
€2m
22 ops.
Buy Volume
€141,874
6 ops.
Sell Volume
33Σ signal
Buys €2m€141,874 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
32,438 shares@ US$4.5720.5% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-036162:0
25 of 139 declarations
Acerca de Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. es una empresa centrada en el desarrollo de soluciones médicas innovadoras. Se especializa en la creación de dispositivos médicos para el tratamiento de enfermedades cardiovasculares y otras afecciones crónicas.